Invivyd (IVVD) EPS (Basic) Growth (1y) (2022 - 2025)
Invivyd (IVVD) EPS (Basic) Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 88.81% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,201.33% |
| 10 | Invivyd | 105.60 Mn | -121.09 Mn | 16.07 Mn | 54.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.51% |
| Sep 30, 2025 | 86.74% |
| Jun 30, 2025 | 69.13% |
| Mar 31, 2025 | 79.19% |
| Dec 31, 2024 | 77.56% |
| Sep 30, 2024 | -27.96% |
| Jun 30, 2024 | 16.11% |
| Mar 31, 2024 | -87.64% |
| Dec 31, 2023 | -55.71% |
| Sep 30, 2023 | 16.78% |
| Jun 30, 2023 | 8.60% |
| Mar 31, 2023 | 64.57% |
| Dec 31, 2022 | 77.12% |
| Sep 30, 2022 | 49.94% |
| Jun 30, 2022 | 99.70% |